McKesson executives reaped personal gains from generics price-fixing scheme, lawsuit claims

29th May 2019 Uncategorised 0

So far, the massive generic drug price-fixing probe has seemingly centered on the drugmakers themselves. Now, an investor lawsuit says drug distribution giant McKesson is in the mix, too—and that executives personally profited off the scheme.

More: McKesson executives reaped personal gains from generics price-fixing scheme, lawsuit claims
Source: fierce